• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014年至2024年关于免疫在三阴性乳腺癌中作用的基础知识与研究:一项文献计量分析

Fundamental knowledge and research regarding the role of immunity in triple-negative breast cancer from 2014-2024: A bibliometric analysis.

作者信息

Li Xudong, Lou Chun, Ren He, Cui Lina, Chen Kexin

机构信息

Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.

Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.

出版信息

Hum Vaccin Immunother. 2025 Dec;21(1):2483022. doi: 10.1080/21645515.2025.2483022. Epub 2025 Mar 26.

DOI:10.1080/21645515.2025.2483022
PMID:40135819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11951696/
Abstract

Immunity has vital research value and promising applications in triple-negative breast cancer (TNBC). Nevertheless, few bibliometric analyses have systematically investigated this area. This study aimed to comprehensively review the collaboration and impact of countries, institutions, authors, and journals on the role of immunity in TNBC from a bibliometric perspective, evaluate the keyword co-occurrence of the knowledge structure, and identify hot trends and emerging topics. Articles and reviews related to immunity in TNBC were retrieved from the Web of Science core collection using subject search. A bibliometric study was conducted primarily using CiteSpace and VOSviewer. A total of 3,104 articles and reviews were included from January 1, 2014, through December 31, 2024. The number of articles on immunization in TNBC is rising. These publications are mainly from 415 institutions in 82 countries, led by China and the USA. Among these publications, published the most papers, while was co-cited the most. The most productive journals focused on molecular biology, biological immunology, and clinical medicine. Furthermore, co-citation analysis revealed that tumor microenvironment, biomarkers, and immune checkpoint inhibitors are current and developing research areas. The keywords and are also likely to be new trends and focal points for future research. This study adopted bibliometric and visualization methods to provide a comprehensive review of the research on immunization in TNBC. This article will help researchers better understand the dynamic evolution of the role of immunity in TNBC and identify areas for future research.

摘要

免疫在三阴性乳腺癌(TNBC)中具有重要的研究价值和广阔的应用前景。然而,很少有文献计量分析系统地研究这一领域。本研究旨在从文献计量学角度全面综述各国、机构、作者和期刊在免疫在TNBC中的作用方面的合作与影响,评估知识结构的关键词共现情况,识别热点趋势和新兴主题。通过主题检索从Web of Science核心合集中检索与TNBC免疫相关 的文章和综述。主要使用CiteSpace和VOSviewer进行文献计量学研究。纳入了2014年1月1日至2024年12月31日期间的3104篇文章和综述。TNBC免疫相关文章数量正在上升。这些出版物主要来自82个国家的415个机构,以中国和美国为首。在这些出版物中, 发表的论文最多,而 被共引次数最多。产出最多的期刊集中在分子生物学、生物免疫学和临床医学领域。此外,共引分析表明肿瘤微环境、生物标志物和免疫检查点抑制剂是当前和正在发展的研究领域。关键词 和 也可能是未来研究的新趋势和重点。本研究采用文献计量学和可视化方法对TNBC免疫研究进行了全面综述。本文将帮助研究人员更好地了解免疫在TNBC中作用的动态演变,并确定未来的研究领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/f94dca65a047/KHVI_A_2483022_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/0c22443dd34d/KHVI_A_2483022_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/36d2515c69ec/KHVI_A_2483022_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/17da580e9607/KHVI_A_2483022_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/7bfeda7a606d/KHVI_A_2483022_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/a02df1e619b3/KHVI_A_2483022_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/82e4eb1b5cdf/KHVI_A_2483022_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/cc167c50669e/KHVI_A_2483022_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/f94dca65a047/KHVI_A_2483022_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/0c22443dd34d/KHVI_A_2483022_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/36d2515c69ec/KHVI_A_2483022_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/17da580e9607/KHVI_A_2483022_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/7bfeda7a606d/KHVI_A_2483022_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/a02df1e619b3/KHVI_A_2483022_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/82e4eb1b5cdf/KHVI_A_2483022_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/cc167c50669e/KHVI_A_2483022_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d9e/11951696/f94dca65a047/KHVI_A_2483022_F0008_OC.jpg

相似文献

1
Fundamental knowledge and research regarding the role of immunity in triple-negative breast cancer from 2014-2024: A bibliometric analysis.2014年至2024年关于免疫在三阴性乳腺癌中作用的基础知识与研究:一项文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2483022. doi: 10.1080/21645515.2025.2483022. Epub 2025 Mar 26.
2
Global research trends and prospects related to tumor microenvironment within Triple Negative Breast Cancer: a bibliometric analysis.全球三阴性乳腺癌肿瘤微环境相关研究趋势和前景:文献计量分析。
Front Immunol. 2023 Dec 4;14:1261290. doi: 10.3389/fimmu.2023.1261290. eCollection 2023.
3
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.肿瘤微环境中 CD39-CD73-eAdo/A2aR 研究的现状和趋势:文献计量学分析。
Front Immunol. 2024 Aug 12;15:1427380. doi: 10.3389/fimmu.2024.1427380. eCollection 2024.
4
Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022.免疫治疗乳腺癌的知识图谱:2013 年至 2022 年的文献计量分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2335728. doi: 10.1080/21645515.2024.2335728. Epub 2024 Apr 2.
5
Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024).子宫内膜癌免疫治疗的全球研究趋势与重点:一项全面的文献计量洞察与可视化分析(2012 - 2024年)
Front Immunol. 2025 Apr 8;16:1571800. doi: 10.3389/fimmu.2025.1571800. eCollection 2025.
6
Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.全球肿瘤免疫微环境(TIME)相关出版物的生产力和研究趋势:一项文献计量学研究。
Eur J Med Res. 2023 Jul 10;28(1):229. doi: 10.1186/s40001-023-01195-3.
7
A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus.乳腺癌免疫治疗药物耐药性的文献计量分析:趋势、主题和研究重点。
Front Immunol. 2024 Aug 12;15:1452303. doi: 10.3389/fimmu.2024.1452303. eCollection 2024.
8
The top 100 most cited articles on triple-negative breast cancer: a bibliometric analysis.100 篇被引频次最高的三阴性乳腺癌相关文献的计量分析
Clin Exp Med. 2023 Jun;23(2):175-201. doi: 10.1007/s10238-022-00800-9. Epub 2022 Apr 13.
9
Therapeutic potential of triple-negative breast cancer immune checkpoint blockers: A 21-year bibliometric analysis.三阴性乳腺癌免疫检查点阻断剂的治疗潜力:一项为期21年的文献计量分析。
Medicine (Baltimore). 2025 Mar 7;104(10):e41739. doi: 10.1097/MD.0000000000041739.
10
Research hotspots and frontiers of machine learning in renal medicine: a bibliometric and visual analysis from 2013 to 2024.肾脏医学中机器学习的研究热点与前沿:2013年至2024年的文献计量学与可视化分析
Int Urol Nephrol. 2025 Mar;57(3):907-928. doi: 10.1007/s11255-024-04259-3. Epub 2024 Oct 30.

本文引用的文献

1
Hybrid Cell Membrane-Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple-Negative Breast Cancer.用于协同声动力疗法和免疫疗法治疗三阴性乳腺癌的混合细胞膜包覆纳米颗粒
Adv Healthc Mater. 2025 Jan;14(3):e2404184. doi: 10.1002/adhm.202404184. Epub 2024 Nov 21.
2
Oxygen self-supplying nanoradiosensitizer activates cGAS-STING pathway to enhance radioimmunotherapy of triple negative breast cancer.供氧自供纳米放射增敏剂激活 cGAS-STING 通路增强三阴性乳腺癌的放免治疗。
J Control Release. 2024 Dec;376:794-805. doi: 10.1016/j.jconrel.2024.10.049. Epub 2024 Nov 1.
3
Metal-Phenolic Vehicles Potentiate Cycle-Cascade Activation of Pyroptosis and cGAS-STING Pathway for Tumor Immunotherapy.
金属-酚醛载体增强细胞焦亡和 cGAS-STING 通路的级联激活用于肿瘤免疫治疗。
ACS Nano. 2024 Aug 27;18(34):23727-23740. doi: 10.1021/acsnano.4c08613. Epub 2024 Aug 18.
4
Research hotspots and frontiers of neoadjuvant therapy in triple-negative breast cancer: a bibliometric analysis of publications between 2002 and 2023.三阴性乳腺癌新辅助治疗的研究热点和前沿:2002 年至 2023 年文献的计量学分析。
Int J Surg. 2024 Aug 1;110(8):4976-4992. doi: 10.1097/JS9.0000000000001586.
5
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.自体患者来源耗竭纳米 T 细胞利用肿瘤免疫逃逸来实施有效的癌症治疗。
Mol Cancer. 2024 May 9;23(1):83. doi: 10.1186/s12943-024-01997-x.
6
Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer.二硫键连接的细胞焦亡调节因子的多组学分析及治疗潜力揭示糖原合酶1是三阴性乳腺癌二硫键连接的细胞焦亡触发靶点。
MedComm (2020). 2024 Feb 28;5(3):e502. doi: 10.1002/mco2.502. eCollection 2024 Mar.
7
Transforming Intratumor Bacteria into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer.将肿瘤内细菌转化为免疫增强剂以逆转冷肿瘤,增强三阴性乳腺癌的免疫化学动力学治疗。
J Am Chem Soc. 2023 Dec 6;145(48):26296-26307. doi: 10.1021/jacs.3c09472. Epub 2023 Nov 21.
8
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer.乳腺癌靶向治疗和免疫治疗的临床进展。
Mol Cancer. 2023 Jul 6;22(1):105. doi: 10.1186/s12943-023-01805-y.
9
Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation.工程化纳米颗粒通过阻断 CD24 和调节线粒体动力学来增强三阴性乳腺癌的治疗效果。
J Control Release. 2023 Mar;355:211-227. doi: 10.1016/j.jconrel.2023.01.075. Epub 2023 Feb 7.
10
Breast Cancer Statistics, 2022.2022 年乳腺癌统计数据。
CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3.